FDA

FDA

ORG Government / Drug and Medical Device Regulation Momentum 61.2ML Momentum Score (0-100). Weighted composite of 9 features: mention velocity, article breadth, relationship density, deal context, recency, market cap, enrichment completeness, mention concentration, entity type. CRITICALPSI regime classification. QUIET (<0.3): baseline activity. NORMAL (0.3-0.5): typical deal flow. ELEVATED (0.5-0.7): above-average signals. HIGH (0.7-0.85): significant activity. EXTREME (>0.85): exceptional signal concentration. Primary: Spectral Shift

FDA (6,900 employees, $6.5B budget) regulates drugs, devices, biologics, and food safety covering ~20% of US consumer spending. Approved first HDV chronic infection treatment and expanded sunscreen ingredient options in 2025; issued draft guidance accelerating cell/gene therapy pathways and reducing animal testing requirements for oncology drugs.

-0.26

PSI ScorePlocamium Signal Index - composite z-score from 5 orthogonal signals: news frequency, targeted sentiment, graph centrality, regulatory filings, and clinical trial activity.

61.2

MomentumML Momentum Score (0-100). Weighted composite of 9 features including mention velocity, article breadth, deal context, and relationship density. Retrained weekly.

ConfidenceSignal confidence - percentage of PSI sub-signals with sufficient data (30+ observations). Higher confidence means the PSI score is based on more complete data.

ConnectionsDegree centrality - number of unique entities this entity co-occurs with in news signals and articles. Higher = more connected in the intelligence network.

FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).

PSI Intelligence

30-Day Trend

Signal Decomposition

Attention Cascade

-0.550

Narrative Drift

0.048

Spectral Shift

429.102

Sentiment-Momentum Divergence

0.000

Source Concentration

0.756

Signal

FDA is graph community structure is reorganizing around this entity — relationship patterns are changing (primary driver: Spectral Shift).

Driver

Ranked #979 of 1191 in Government — in line with sector peers. PSI stable vs yesterday (-0.28).

Action

Baseline conditions. Continue standard monitoring cadence.

Peer Comparison

979 of 1191

Sector Rank

-0.95

Peer Z-Score

18%

Sector Percentile

Network Analysis

46 Degree Centrality

Ego Network (top connections)

Centrality History

Entity	Weight	Status
White House	48	STABLE
PlocamiumAI	43	NEW
United States	43	STABLE
HHS	35	STABLE
AstraZeneca	29	NEW
Dr.	28	STABLE
WASHINGTON	25	STABLE
Robert F. Kennedy Jr.	24	NEW
CMS	17	STABLE
Eli Lilly	15	NEW
China	15	STABLE
RFK Jr.	15	NEW
Europe	14	STABLE
Americans	14	NEW
Pfizer	14	STABLE
President	12	STABLE
CEO	10	STABLE
AP	9	STABLE
Reuters	9	STABLE
U.S. Department of Health and Human Services	9	NEW
Canada	8	STRENGTHENED
Supreme Court	8	STABLE
Merck	8	STRENGTHENED
Senate	7	NEW
Asia	6	STABLE
Donald Trump	6	STABLE
Florida	5	NEW
Iran	5	STABLE
GOP	5	STABLE
Politico	5	NEW

Article Coverage (0)

Date	Lane	Title
No Plocamium-authored coverage yet. This entity surfaces in upstream signals (news, filings, trials) but has not yet been a primary subject of a published article. Watch this entity to be alerted when one is published.

Request Access

Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.

FDA+ Note this entity

Request Access